Treating atopic dermatitis at the source: corrective barrier repair therapy based upon new pathogenic insights

References

• Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv. Lipid Res. 24, 1–26 (1991).
   PubMedGoogle Scholar
• Caubet C, Jonca N, Brattsand M et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J. Invest. Dermatol. 122(5), 1235–1244 (2004).
   PubMed Web of Science ®Google Scholar
• Brattsand M, Stefansson K, Lundh C, Haasum Y, Egelrud T. A proteolytic cascade of kallikreins in the stratum corneum. J. Invest. Dermatol. 124(1), 198–203 (2005).
   PubMed Web of Science ®Google Scholar
• Lin TK, Crumrine D, Ackerman LD et al. Cellular changes that accompany shedding of human corneocytes. J. Invest. Dermatol. 32(10), 2430–2439 (2012).
   Google Scholar
• Braff MH, Di Nardo A, Gallo RL. Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J. Invest. Dermatol. 124(2), 394–400 (2005).
   PubMed Web of Science ®Google Scholar
• Oren A, Ganz T, Liu L, Meerloo T. In human epidermis, β-defensin 2 is packaged in lamellar bodies. Exp. Mol. Pathol. 74(2), 180–182 (2003).
   PubMedGoogle Scholar
• Aberg KM, Radek KA, Choi EH et al. Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J. Clin. Invest. 117(11), 3339–3349 (2007).
   PubMed Web of Science ®Google Scholar
• Elias PM. Stratum corneum defensive functions: an integrated view. J. Invest. Dermatol. 125(2), 183–200 (2005).
   PubMed Web of Science ®Google Scholar
• Elias PM, Choi EH. Interactions among stratum corneum defensive functions. Exp. Dermatol. 14(10), 719–726 (2005).
   PubMed Web of Science ®Google Scholar
• Elias PM. The skin barrier as an innate immune element. Semin. Immunopathol. 29(1), 3–14 (2007).
   PubMed Web of Science ®Google Scholar
• Cork MJ, Danby SG, Vasilopoulos Y et al. Epidermal barrier dysfunction in atopic dermatitis. J. Invest. Dermatol. 129(8), 1892–1908 (2009).
   PubMed Web of Science ®Google Scholar
• Sugarman JL, Fluhr JW, Fowler AJ, Bruckner T, Diepgen TL, Williams ML. The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch. Dermatol. 139(11), 1417–1422 (2003).
   PubMed Web of Science ®Google Scholar
• Seidenari S, Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm. Venereol. 75(6), 429–433 (1995).
   PubMed Web of Science ®Google Scholar
• Eberlein-König B, Schäfer T, Huss-Marp J et al. Skin surface pH, stratum corneum hydration, trans-epidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children. Acta Derm. Venereol. 80(3), 188–191 (2000).
   PubMed Web of Science ®Google Scholar
• Chamlin SL, Kao J, Frieden IJ et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J. Am. Acad. Dermatol. 47(2), 198–208 (2002).
   PubMed Web of Science ®Google Scholar
• Denda M, Sato J, Tsuchiya T, Elias PM, Feingold KR. Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: implication for seasonal exacerbations of inflammatory dermatoses. J. Invest. Dermatol. 111(5), 873–878 (1998).
   PubMed Web of Science ®Google Scholar
• Proksch E, Fölster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J. Dermatol. Sci. 43(3), 159–169 (2006).
   PubMed Web of Science ®Google Scholar
• Boguniewicz M, Leung DY. 10. Atopic dermatitis. J. Allergy Clin. Immunol. 117(2 Suppl. Mini-Primer), S475–S480 (2006).
   PubMed Web of Science ®Google Scholar
• Baker BS. The role of microorganisms in atopic dermatitis. Clin. Exp. Immunol. 144(1), 1–9 (2006).
   PubMed Web of Science ®Google Scholar
• Elias PM, Wood LC, Feingold KR. Relationship of the epidermal permeability barrier to irritant contact dermatitis. Immunol. Allergy Clin. North America 17, 417–430 (1997).
   Google Scholar
• Elias PM, Wood LC, Feingold KR. Epidermal pathogenesis of inflammatory dermatoses. Am. J. Contact Dermatitis 10(3), 119–126 (1999).
   PubMedGoogle Scholar
• Elias PM, Feingold KR. Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch. Dermatol. 137(8), 1079–1081 (2001).
   PubMed Web of Science ®Google Scholar
• Taïeb A. Hypothesis: from epidermal barrier dysfunction to atopic disorders. Contact Derm. 41(4), 177–180 (1999).
   PubMed Web of Science ®Google Scholar
• Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br. J. Dermatol. 149(3), 582–589 (2003).
   PubMed Web of Science ®Google Scholar
• Draelos ZD. New treatments for restoring impaired epidermal barrier permeability: skin barrier repair creams. Clin. Dermatol. 30(3), 345–348 (2012).
   PubMed Web of Science ®Google Scholar
• Aly R, Maibach HI, Shinefield HR. Microbial flora of atopic dermatitis. Arch. Dermatol. 113(6), 780–782 (1977).
   PubMedGoogle Scholar
• Boguniewicz M, Schmid-Grendelmeier P, Leung DY. Atopic dermatitis. J. Allergy Clin. Immunol. 118(1), 40–43 (2006).
   PubMedGoogle Scholar
• Ramirez de Knott HM, McCormick TS, Kalka K et al. Cutaneous hypersensitivity to Malassezia sympodialis and dust mite in adult atopic dermatitis with a textile pattern. Contact Dermatitis 54, 92–99 (2006).
   PubMedGoogle Scholar
• Leung DY, Bieber T. Atopic dermatitis. Lancet 361(9352), 151–160 (2003).
   PubMed Web of Science ®Google Scholar
• Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347(15), 1151–1160 (2002).
   PubMed Web of Science ®Google Scholar
• Aberg KM, Man MQ, Gallo RL et al. Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J. Invest. Dermatol. 128(4), 917–925 (2008).
   PubMedGoogle Scholar
• Miller SJ, Aly R, Shinefeld HR, Elias PM. In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch. Dermatol. 124(2), 209–215 (1988).
   PubMedGoogle Scholar
• Fluhr JW, Elias PM. Stratum corneum pH: Formation and function of the ‘acid mantle’. Exog. Dermatol. 1, 163–175 (2002).
   Google Scholar
• Bibel DJ, Aly R, Shinefield HR. Antimicrobial activity of sphingosines. J. Invest. Dermatol. 98(3), 269–273 (1992).
   PubMed Web of Science ®Google Scholar
• Thormar H, Hilmarsson H. The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents. Chem. Phys. Lipids 150(1), 1–11 (2007).
   PubMed Web of Science ®Google Scholar
• Clarke SR, Mohamed R, Bian L et al. The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. Cell Host Microbe 1(3), 199–212 (2007).
   PubMedGoogle Scholar
• Nomura I, Goleva E, Howell MD et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J. Immunol. 171(6), 3262–3269 (2003).
   PubMed Web of Science ®Google Scholar
• Zaiou M, Nizet V, Gallo RL. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J. Invest. Dermatol. 120(5), 810–816 (2003).
   PubMed Web of Science ®Google Scholar
• Komatsuzawa H, Ouhara K, Yamada S et al. Innate defences against methicillin-resistant Staphylococcus aureus (MRSA) infection. J. Pathol. 208(2), 249–260 (2006).
   PubMedGoogle Scholar
• Kisich KO, Howell MD, Boguniewicz M, Heizer HR, Watson NU, Leung DY. The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on β-defensin 3. J. Invest. Dermatol. 127(10), 2368–2380 (2007).
   PubMed Web of Science ®Google Scholar
• Lomholt H, Andersen KE, Kilian M. Staphylococcus aureus clonal dynamics and virulence factors in children with atopic dermatitis. J. Invest. Dermatol. 125(5), 977–982 (2005).
   PubMedGoogle Scholar
• Wehner J, Neuber K. Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema. Br. J. Dermatol. 145(2), 302–305 (2001).
   PubMed Web of Science ®Google Scholar
• Lehmann HS, Heaton T, Mallon D, Holt PG. Staphylococcal enterotoxin-B-mediated stimulation of interleukin-13 production as a potential aetiologic factor in eczema in infants. Int. Arch. Allergy Immunol. 135(4), 306–312 (2004).
   PubMedGoogle Scholar
• Langer K, Breuer K, Kapp A, Werfel T. Staphylococcus aureus-derived enterotoxins enhance house dust mite-induced patch test reactions in atopic dermatitis. Exp. Dermatol. 16(2), 124–129 (2007).
   PubMedGoogle Scholar
• Leung DY, Harbeck R, Bina P et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J. Clin. Invest. 92(3), 1374–1380 (1993).
   PubMed Web of Science ®Google Scholar
• Gould HJ, Takhar P, Harries HE, Chevretton E, Sutton BJ. The allergic march from Staphylococcus aureus superantigens to immunoglobulin E. Chem. Immunol. Allergy 93, 106–136 (2007).
   PubMedGoogle Scholar
• Sonkoly E, Muller A, Lauerma AI et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J. Allergy Clin. Immunol. 117(2), 411–417 (2006).
   PubMed Web of Science ®Google Scholar
• Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N. Engl. J. Med. 365(14), 1315–1327 (2011).
   PubMed Web of Science ®Google Scholar
• Sandilands A, Smith FJ, Irvine AD, McLean WH. Filaggrin’s fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J. Invest. Dermatol. 127(6), 1282–1284 (2007).
   PubMed Web of Science ®Google Scholar
• Weidinger S, Rodríguez E, Stahl C et al. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J. Invest. Dermatol. 127(3), 724–726 (2007).
   PubMed Web of Science ®Google Scholar
• Gruber R, Elias PM, Crumrine D et al. Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am. J. Pathol. 178(5), 2252–2263 (2011).
   PubMed Web of Science ®Google Scholar
• Presland R, Rothnagal J, Lawrence O. Profilaggrin and the fused S100 family of calcium-binding proteins. In: Skin Barrier. Elias P, Feingold K (Eds). Taylor & Francis, NY, USA, 111–140 (2006).
   Google Scholar
• Yoneda K, Nakagawa T, Lawrence OT et al. Interaction of the profilaggrin N-terminal domain with loricrin in human cultured keratinocytes and epidermis. J. Invest. Dermatol. 132(4), 1206–1214 (2012).
   PubMedGoogle Scholar
• Hoste E, Kemperman P, Devos M et al. Caspase-14 is required for filaggrin degradation to natural moisturizing factors in the skin. J. Invest. Dermatol. 131(11), 2233–2241 (2011).
   PubMed Web of Science ®Google Scholar
• Scott IR, Harding CR. Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev. Biol. 115(1), 84–92 (1986).
   PubMed Web of Science ®Google Scholar
• Krien PM, Kermici M. Evidence for the existence of a self-regulated enzymatic process within the human stratum corneum -an unexpected role for urocanic acid. J. Invest. Dermatol. 115(3), 414–420 (2000).
   PubMed Web of Science ®Google Scholar
• Kelsell DP, Byrne C. SNPing at the epidermal barrier. J. Invest. Dermatol. 131(8), 1593–1595 (2011).
   PubMedGoogle Scholar
• Marenholz I, Rivera VA, Esparza-Gordillo J et al. Association screening in the epidermal differentiation complex (EDC) identifies an SPRR3 repeat number variant as a risk factor for eczema. J. Invest. Dermatol. 131(8), 1644–1649 (2011).
   PubMedGoogle Scholar
• Walley AJ, Chavanas S, Moffatt MF et al. Gene polymorphism in Netherton and common atopic disease. Nat. Genet. 29(2), 175–178 (2001).
   PubMed Web of Science ®Google Scholar
• Fortugno P, Bresciani A, Paolini C et al. Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis. J. Invest. Dermatol. 131(11), 2223–2232 (2011).
   PubMed Web of Science ®Google Scholar
• Hachem JP, Wagberg F, Schmuth M et al. Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J. Invest. Dermatol. 126(7), 1609–1621 (2006).
   PubMed Web of Science ®Google Scholar
• Hachem JP, Crumrine D, Fluhr J, Brown BE, Feingold KR, Elias PM. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J. Invest. Dermatol. 121(2), 345–353 (2003).
   PubMed Web of Science ®Google Scholar
• Komatsu N, Takata M, Otsuki N et al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J. Invest. Dermatol. 118(3), 436–443 (2002).
   PubMed Web of Science ®Google Scholar
• Di Nardo A, Wertz P, Giannetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm. Venereol. 78(1), 27–30 (1998).
   PubMed Web of Science ®Google Scholar
• Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J. Invest. Dermatol. 96(4), 523–526 (1991).
   PubMed Web of Science ®Google Scholar
• Hatano Y, Man MQ, Uchida Y et al. Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis. J. Invest. Dermatol. 129(7), 1824–1835 (2009).
   PubMed Web of Science ®Google Scholar
• Hachem JP, Houben E, Crumrine D et al. Serine protease signaling of epidermal permeability barrier homeostasis. J. Invest. Dermatol. 126(9), 2074–2086 (2006).
   PubMed Web of Science ®Google Scholar
• Demerjian M, Hachem JP, Tschachler E et al. Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2. Am. J. Pathol. 172(1), 86–97 (2008).
   PubMedGoogle Scholar
• Sator PG, Schmidt JB, Hönigsmann H. Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J. Am. Acad. Dermatol. 48(3), 352–358 (2003).
   PubMed Web of Science ®Google Scholar
• Janssens M, van Smeden J, Gooris GS et al. Lamellar lipid organization and ceramide composition in the stratum corneum of patients with atopic eczema. J. Invest. Dermatol. 131(10), 2136–2138 (2011).
   PubMed Web of Science ®Google Scholar
• Cork MJ, Robinson DA, Vasilopoulos Y et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J. Allergy Clin. Immunol. 118(1), 3–21; quiz 22 (2006).
   PubMed Web of Science ®Google Scholar
• Elias PM, Hatano Y, Williams ML. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J. Allergy Clin. Immunol. 121(6), 1337–1343 (2008).
   PubMed Web of Science ®Google Scholar
• Elias PM, Wakefield JS. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Clin. Rev. Allergy Immunol. 41(3), 282–295 (2011).
   PubMed Web of Science ®Google Scholar
• Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr. Opin. Allergy Clin. Immunol. 9(5), 437–446 (2009).
   PubMed Web of Science ®Google Scholar
• Garg A, Chren MM, Sands LP et al. Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch. Dermatol. 137(1), 53–59 (2001).
   PubMed Web of Science ®Google Scholar
• Altemus M, Rao B, Dhabhar FS, Ding W, Granstein RD. Stress-induced changes in skin barrier function in healthy women. J. Invest. Dermatol. 117(2), 309–317 (2001).
   PubMed Web of Science ®Google Scholar
• Denda M, Tsuchiya T, Elias PM, Feingold KR. Stress alters cutaneous permeability barrier homeostasis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278(2), R367–R372 (2000).
   PubMed Web of Science ®Google Scholar
• Choi EH, Demerjian M, Crumrine D et al. Glucocorticoid blockade reverses psychological stress-induced abnormalities in epidermal structure and function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291(6), R1657–R1662 (2006).
   Google Scholar
• Choi EH, Brown BE, Crumrine D et al. Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J. Invest. Dermatol. 124(3), 587–595 (2005).
   PubMedGoogle Scholar
• Hachem JP, Fowler A, Behne M et al. Increased stratum corneum pH promotes activation and release of primary cytokines from the stratum corneum attributable to activation of serine proteases. J. Invest. Dermatol. 119, 258 (2002).
   Google Scholar
• Nylander-Lundqvist E, Bäck O, Egelrud T. IL-1 β activation in human epidermis. J. Immunol. 157(4), 1699–1704 (1996).
   PubMed Web of Science ®Google Scholar
• Hudson TJ. Skin barrier function and allergic risk. Nat. Genet. 38(4), 399–400 (2006).
   PubMed Web of Science ®Google Scholar
• Briot A, Deraison C, Lacroix M et al. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J. Exp. Med. 206(5), 1135–1147 (2009).
   PubMed Web of Science ®Google Scholar
• Kurahashi R, Hatano Y, Katagiri K. IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo. J. Invest. Dermatol. 128(5), 1329–1331 (2008).
   PubMed Web of Science ®Google Scholar
• Hatano Y, Terashi H, Arakawa S, Katagiri K. Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-α and interferon-γ in human epidermis. J. Invest. Dermatol. 124(4), 786–792 (2005).
   PubMed Web of Science ®Google Scholar
• Howell MD, Kim BE, Gao P et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J. Allergy Clin. Immunol. 120(1), 150–155 (2007).
   PubMed Web of Science ®Google Scholar
• Hatano Y, Adachi Y, Elias PM et al. The Th2 cytokine, interleukin-4, abrogates the cohesion of normal stratum corneum in mice: implications for pathogenesis of atopic dermatitis. 22(1), 30–35 (2012).
   Google Scholar
• Kobayashi J, Inai T, Morita K et al. Reciprocal regulation of permeability through a cultured keratinocyte sheet by IFN-γ and IL-4. Cytokine 28(4–5), 186–189 (2004).
   PubMedGoogle Scholar
• Lin TK, Man MQ, Santiago JL et al. Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function. J. Invest. Dermatol. 133(2), 469–478 (2012).
   PubMedGoogle Scholar
• Grether-Beck S, Felsner I, Brenden H et al. Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression. J. Invest. Dermatol. 132(6), 1561–1572 (2012).
   PubMed Web of Science ®Google Scholar
• Ghadially R, Halkier-Sorensen L, Elias PM. Effects of petrolatum on stratum corneum structure and function. J. Am. Acad. Dermatol. 26(3 Pt 2), 387–396 (1992).
   PubMed Web of Science ®Google Scholar
• Brown B, Diembeck W, Hoppe U, Elias P. Fate of topical hydrocarbons in the skin. J. Soc. Cosm. Chem. 46, 1–9 (1995).
   Google Scholar
• Simpson E, Berry T, Tofte S, Hanifin JM, Eichenfield L. EpiCeram for the treatment of mild-to-moderate atopic dermatitis – a pilot study. IID 2008 Kyoto, Japan (2008).
   Google Scholar
• Sugarman JL, Parish LC. Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis. J. Drugs Dermatol. 8(12), 1106–1111 (2009).
   PubMed Web of Science ®Google Scholar
• Man MQ, Feingold KR, Elias PM. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch. Dermatol. 129(6), 728–738 (1993).
   PubMed Web of Science ®Google Scholar
• Mao-Qiang M, Brown BE, Wu-Pong S, Feingold KR, Elias PM. Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch. Dermatol. 131(7), 809–816 (1995).
   PubMed Web of Science ®Google Scholar
• Man MQ M, Feingold KR, Thornfeldt CR, Elias PM. Optimization of physiological lipid mixtures for barrier repair. J. Invest. Dermatol. 106(5), 1096–1101 (1996).
   PubMedGoogle Scholar
• Bikowski J. Case studies assessing a new skin barrier repair cream for the treatment of atopic dermatitis. J. Drugs Dermatol. 8(11), 1037–1041 (2009).
   PubMedGoogle Scholar
• Man MQ, Sun R. Comparative efficacy of various ‘barrier repair’ ingredients and formulations on barrier homeostasis, inflammation, and antimicrobial peptide expression. Presented at: IID 2013. Edinburgh, Scotland, 8–13 May 2013.
   Google Scholar
• Zettersten EM, Ghadially R, Feingold KR, Crumrine D, Elias PM. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin. J. Am. Acad. Dermatol. 37(3 Pt 1), 403–408 (1997).
   PubMed Web of Science ®Google Scholar
• Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J. Clin. Invest. 95(5), 2281–2290 (1995).
   PubMed Web of Science ®Google Scholar
• Yang L, Mao-Qiang M, Taljebini M, Elias PM, Feingold KR. Topical stratum corneum lipids accelerate barrier repair after tape stripping, solvent treatment and some but not all types of detergent treatment. Br. J. Dermatol. 133(5), 679–685 (1995).
   PubMed Web of Science ®Google Scholar
• Hong SP, Kim MJ, Jung MY et al. Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement. J. Invest. Dermatol. 128(12), 2880–2887 (2008).
   PubMed Web of Science ®Google Scholar
• Elias PM. Barrier-repair therapy for atopic dermatitis: corrective lipid biochemical therapy. Exp. Rev. Dermatol. 3, 441–452 (2008).
   Google Scholar